Skip to content

Surveillance for Adverse Events Following Influenza Immunization

Active Surveillance of Adverse Events Following Immunization Among Healthcare Workers Immunized With the Influenza Vaccine

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01318876
Enrollment
7645
Registered
2011-03-21
Start date
2010-10-31
Completion date
2011-02-28
Last updated
2012-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza, Vaccines Adverse Reaction

Keywords

influenza, vaccine safety, adverse events, health care workers

Brief summary

Influenza vaccines are continuously modified to adjust to the virus antigenic shifts or drifts, and its safety profile may vary. While generally considered safe, influenza vaccines have been associated in the past with increases in cases of Guillain-Barré syndrome (1976) and with oculorespiratory syndrome in 2001. Last year, with the vaccination against the pH1N1, an increase of allergic-like reactions was observed. Passive surveillance is collecting notifications of adverse events (AE) on the whole population but the sensitivity of this system is not high and its timeliness is not necessarily optimal. Last year, with the new pandemic Influenza vaccine the investigators piloted a web-based active surveillance of a large number of health care workers (HCW) vaccinated with the new adjuvanted monovalent pH1N1 influenza vaccine (Arepanrix® GSK, Canada). Because healthcare workers (HCW) constituted a well-defined group with general good health and received the Influenza vaccine in priority, this group of people was well suited for monitoring the safety of the influenza vaccine. For this study, 6242 HCW were recruited in three different sites (5183 were from Quebec). A total of 468 events (local reactions, fever, systemic reactions, gastrointestinal and respiratory problems) were reported by 430 HCW. 80% of the HCW recruited completed at least one of the three surveys and 52% responded to all questionnaires. During this surveillance, the investigators didn't have unexpected findings but this active surveillance of adverse events among healthcare workers would have been effective enough to rapidly detect adverse events occurring at a rate ≥ 1 per 200 vaccinees. For this year the investigators want to expand the surveillance to more sites and more participants to be able to detect AE occurring at rates ≥ 1 per 500 vaccinees, and to increase the response rate to all three surveys in participants. The main objective of this project is to estimate in HCW vaccinated against influenza the frequency of adverse events of sufficient severity to cause work absenteeism or medical consultation. This year the network will include 5 Canadian hospitals (Quebec City, Vancouver, Toronto, Halifax, + another one ) with a total enrollment of \>10 000 HCW. This should allow us to detect AE occurring at a rate of ≥ 1 per 500 vaccinees.

Interventions

None listed

Sponsors

GlaxoSmithKline
CollaboratorINDUSTRY
Institut National en Santé Publique du Québec
CollaboratorOTHER
Laval University
CollaboratorOTHER
CHU de Quebec-Universite Laval
CollaboratorOTHER
Mount Sinai Hospital, Canada
CollaboratorOTHER
IWK Health Centre
CollaboratorOTHER
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
CollaboratorOTHER
The Ottawa Hospital
CollaboratorOTHER
University of British Columbia
CollaboratorOTHER
PHAC/CIHR Influenza Research Network
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* To be a healthcare worker from one of the seven Canadian Hospitals participating in the Public Health Agency of Canada/Canadian Institutes for Health Research-Influenza Research Network (PCIRN): Quebec City, Toronto, Halifax, Vancouver, Ottawa and Sherbrooke. * To have been immunized with the influenza vaccine 2010 * To have an email address * To be 18 years old and older * To have sign the consent form

Exclusion criteria

* Pregnant women

Design outcomes

Primary

MeasureTime frame
Number of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in a Medical Consultationat day 8 and 29
Number of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in Work Absenteeism.day 8 and 29

Countries

Canada

Participant flow

Participants by arm

ArmCount
Health Care Workers
HCW who had completed at least 1 survey (n=6269) and not the number of participants enrolled in the study.
6,269
Total6,269

Withdrawals & dropouts

PeriodReasonFG000
Day 29 Surveysurvey not completed-don't know why1,825
Day 8 Surveyemail address invalid96
Day 8 Surveysurvey not completed-don't know why1,724

Baseline characteristics

CharacteristicHealth Care Workers
Age, Categorical
<=18 years
NA Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
6269 Participants
Age Continuous41.77 years
STANDARD_DEVIATION 11.87
Sex: Female, Male
Female
4639 Participants
Sex: Female, Male
Male
1630 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 6,269
serious
Total, serious adverse events
6 / 6,269

Outcome results

Primary

Number of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in a Medical Consultation

Time frame: at day 8 and 29

ArmMeasureValue (NUMBER)
HCW From All SitesNumber of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in a Medical Consultation153 participants
Primary

Number of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in Work Absenteeism.

Time frame: day 8 and 29

ArmMeasureValue (NUMBER)
HCW From All SitesNumber of Participants Who Had Experienced a New Health Problem or the Worsening of an Existing Health Condition That Resulted in Work Absenteeism.254 participants

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026